Bakhu Holdings, Corp. Reports Earnings Results for the Third Quarter Ended April 30, 2019
June 14, 2019 at 07:48 pm
Share
Bakhu Holdings, Corp. announced earnings results for the third quarter ended April 30, 2019. For the third quarter, the company announced operating loss was USD 10.510 million compared to USD 93,101 a year ago. Net loss was USD 10.510 million compared to USD 99,726 a year ago. Basic loss per share was USD 0.04 compared to USD 0.38 a year ago. For the nine months, operating loss was USD 10.632 million compared to USD 201,717 a year ago. Net loss was USD 10.632 million compared to USD 216,232 a year ago. Basic loss per share was USD 0.08 compared to USD 0.83 a year ago.
Bakhu Holdings, Corp. is a development-stage company. The Company hold a license from Cell Science to plant cell-extraction and replication technology and related equipment, processes, and formulations (the Licensed Science), to produce, manufacture, and sell cannabis-related byproducts - sometimes referred to as cannabinoids in North America, Central America, and the Caribbean for medical, food additive, and recreational uses. The Company is focused on testing and commercializing cannabis plant cell-extraction and replication technologies under a technology license granted by Cell Science. It also intends to sublicense the Licensed Science to third party sub-licensees. The Company has not generated any revenue.
BAKHU HOLDINGS, CORP. 
